SCHEMBL14060226

SCHEMBL14060226

CN(C)C(=O)c1ccc(-c2ccc3c(NCCC4CC4)c(C#N)nnc3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 10/20 0.44
▸ CYP1A2 P05177 7/20 0.40
▸ CLK4 Q9HAZ1 5/20 0.40
▸ CYP3A4 P08684 4/20 0.40
▸ USP2 O75604 4/20 0.40
▸ ALDH1A1 P00352 7/20 0.38
▸ HSD17B10 Q99714 7/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CYP2C9 P11712 1/20 0.37
▸ ACP1 P24666 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14059470 0.92 FYN (0.42) LRRK2CYP3A4
SCHEMBL14059970 0.88 LRRK2 (0.54) LRRK2CYP1A2CLK4CYP3A4USP2
SCHEMBL14062308 0.87 LRRK2 (0.55) LRRK2
SCHEMBL14059515 0.84 LRRK2 (0.58) LRRK2
SCHEMBL14059769 0.83 LRRK2 (0.46) LRRK2
SCHEMBL14059181 0.82 LRRK2 (0.46) LRRK2ALDH1A1
SCHEMBL14059647 0.82 LRRK2 (0.46) LRRK2CLK4
SCHEMBL14059307 0.82 LRRK2 (0.66) LRRK2
SCHEMBL14059582 0.80 LRRK2 (0.69) LRRK2
SCHEMBL14059581 0.80 LRRK2 (0.69) LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP disclosed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO disclosed
Send feedback